With the resolution of 3 May 2024, the Italian Medicines Agency updated the Handbook of Hospital-Local community Care Continuity (PHT) by shifting medicinal products belonging to specific pharmacological classes, from the “A-PHT” classification regime to the “A” class (Offical Gazette, General Series No.108 of 10-05-2024).

In that regard, AIFA’s Scientific and Economic Committee (CSE) has identified glyptins, a category of antidiabetic drugs, as a pharmacological class to be reclassified, since the criteria are met which facilitate access through local pharmacies.